Nasal delivery of an IgM offers broad protection from SARS-CoV-2 variants is a research paper published in Nature (2021). On theSindex it has a DataRank of 0. It has been cited 186 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCATS NIH HHS
Grant: UL1 TR001439
NIH HHS
Grant: AI134907
NIAID NIH HHS
Grant: R01 AI134907
NCI NIH HHS
Grant: R15 CA182769
National Institutes of Health
Grant: 1R15CA182769-01A1
Novel Therapeutics Targeting HER2 Positive Breast Cancer Brain Metastasis
National Institutes of Health
Grant: 5UL1TR001439-07
UTMB Clinical and Translational Science Award
National Institutes of Health
Grant: 3R01AI134907-03S2
A High-Throughput Platform for COVID-19 Serodiagnosis, Vaccine Evaluation, and Drug Discovery
FWCI
9.59
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Antibody attributes that predict the neutralization and effector function of polyclonal responses to SARS-CoV-2
Additional file 1 of Antibody attributes that predict the neutralization and effector function of polyclonal responses to SARS-CoV-2